Tag: AHA2022
Ablation as first-line treatment cuts AF progression compared to antiarrhythmic drugs
Ablation as a first-line treatment for atrial fibrillation (AF) disease is associated with significantly better clinical outcomes than starting with antiarrhythmic drugs.
These were the...